biote (BTMD) Revenue & Revenue Breakdown
biote Revenue Highlights
Latest Revenue (Y)
$192.22M
Latest Revenue (Q)
$47.96M
Main Segment (Y)
Product Revenue
Main Geography (Y)
UNITED STATES
biote Revenue by Period
biote Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2025-12-31 | $192.22M | -2.52% |
| 2024-12-31 | $197.19M | 6.38% |
| 2023-12-31 | $185.36M | 12.37% |
| 2022-12-31 | $164.96M | 18.34% |
| 2021-12-31 | $139.40M | 19.58% |
| 2020-12-31 | $116.57M | 5.99% |
| 2019-12-31 | $109.98M | - |
biote generated $192.22M in revenue during NA 2025, up -2.52% compared to the previous quarter, and up 164.90% compared to the same period a year ago.
biote Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-09-30 | $47.96M | -1.86% |
| 2025-06-30 | $48.86M | -0.26% |
| 2025-03-31 | $48.99M | -1.69% |
| 2024-12-31 | $49.83M | -3.02% |
| 2024-09-30 | $51.38M | 4.50% |
| 2024-06-30 | $49.17M | 5.05% |
| 2024-03-31 | $46.80M | 2.41% |
| 2023-12-31 | $45.70M | 0.32% |
| 2023-09-30 | $45.56M | -7.51% |
| 2023-06-30 | $49.26M | 9.84% |
| 2023-03-31 | $44.84M | 0.80% |
| 2022-12-31 | $44.48M | 5.99% |
| 2022-09-30 | $41.97M | 1.48% |
| 2022-06-30 | $41.36M | 11.35% |
| 2022-03-31 | $37.14M | -1.05% |
| 2021-12-31 | $37.54M | 5.54% |
| 2021-09-30 | $35.57M | 2.35% |
| 2021-06-30 | $34.75M | 10.17% |
| 2021-03-31 | $31.54M | 2.31% |
| 2020-12-31 | $30.83M | - |
biote generated $47.96M in revenue during Q3 2025, up -1.86% compared to the previous quarter, and up 97.53% compared to the same period a year ago.
biote Revenue Breakdown
biote Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 25 | Dec 24 | Dec 23 | Dec 22 |
|---|---|---|---|---|
| Dietary Supplements | $42.88M | $36.02M | $38.09M | $32.41M |
| Other Service Revenue | $2.86M | $2.27M | $697.00K | - |
| Product Revenue | $186.92M | $192.24M | $182.57M | $163.13M |
| Service Revenue | $5.29M | $4.95M | $2.79M | $1.82M |
| Training Service Revenue | $1.08M | $1.46M | $1.17M | $973.00K |
biote's latest annual revenue breakdown by segment (product or service), as of Dec 25: Product Revenue (78.20%), Dietary Supplements (17.94%), Service Revenue (2.22%), Other Service Revenue (1.20%), and Training Service Revenue (0.45%).
Quarterly Revenue by Product
| Product/Service | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Other Service Revenue | $583.00K | $433.00K | $535.00K | $1.31M | $1.35M | $702.00K | $221.00K | $206.00K | $171.00K | $178.00K | $142.00K | - | - | - |
| Dietary Supplements | $11.68M | $11.18M | $10.75M | $9.27M | $18.31M | $10.32M | $7.39M | $9.13M | $8.47M | $12.15M | $8.33M | $24.46M | $8.07M | $7.95M |
| Product Revenue | $45.29M | $46.95M | $47.66M | $47.02M | $96.40M | $49.81M | $46.03M | $44.94M | $44.83M | $48.65M | $44.16M | $122.34M | $41.57M | $40.79M |
| Service Revenue | $1.12M | $1.00M | $1.21M | $1.97M | $2.60M | $1.58M | $769.00K | $768.00K | $726.00K | $605.00K | $688.00K | $1.25M | $396.00K | $570.00K |
| Training Service Revenue | $190.00K | $227.00K | $333.00K | $326.00K | $609.00K | $573.00K | $274.00K | $983.00K | $321.00K | $202.00K | $-336.00K | $617.00K | $186.00K | $356.00K |
biote's latest quarterly revenue breakdown by segment (product or service), as of Dec 25: Product Revenue (76.94%), Dietary Supplements (19.85%), Service Revenue (1.90%), Other Service Revenue (0.99%), and Training Service Revenue (0.32%).
biote Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 25 | Dec 24 | Dec 23 | Dec 22 |
|---|---|---|---|---|
| Non-US | $1.00M | - | - | - |
| UNITED STATES | $191.20M | $196.20M | $181.84M | $164.52M |
| All Other Country | - | $1.02M | $735.00K | $434.00K |
biote's latest annual revenue breakdown by geography, as of Dec 25: UNITED STATES (99.48%), and Non-US (0.52%).
Quarterly Revenue by Country
| Country | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| UNITED STATES | $46.20M | $47.70M | $48.60M | $48.70M | $100.55M | $49.99M | $45.66M | $43.44M | $44.57M | $49.16M | $44.67M | $121.49M | $41.85M | $41.25M |
| All Other Country | - | $248.00K | $252.00K | $246.00K | $825.00K | $-185.00K | $379.00K | $206.00K | $261.00K | $97.00K | $171.00K | $281.00K | $116.00K | $110.00K |
biote's latest quarterly revenue breakdown by geography, as of Dec 25: UNITED STATES (100.00%).
biote Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| LUCD | Lucid Diagnostics | $4.71B | $1.21B |
| BTMD | biote | $192.22M | $47.96M |
| ANIK | Anika Therapeutics | $112.82M | $27.82M |
| SPRO | Spero Therapeutics | $66.80M | $11.80M |
| JYNT | Joint | $54.90M | $13.38M |
| SCLX | Scilex | $30.25M | $10.56M |
| MCRB | Seres Therapeutics | $789.00K | $351.00K |
| ACTU | Actuate Therapeutics | - | - |
| INO | Inovio Pharmaceuticals | - | - |
| ABOS | Acumen Pharmaceuticals | - | - |
| VOR | Vor Biopharma | - | - |